Evaluating Therapeutic Inertia in Two Telehealth Interventions for Type 2 Diabetes: Secondary Analyses of a Randomized Trial-Reference-Cited by-同舟云学术

Evaluating Therapeutic Inertia in Two Telehealth Interventions for Type 2 Diabetes: Secondary Analyses of a Randomized Trial

Published:2024-06-01 Issue:6 Volume:30 Page:e1790-e1797
ISSN:1530-5627
Container-title:Telemedicine and e-Health
language:en
Short-container-title:Telemedicine and e-Health

Author:

Duffy Ryan A.¹^ORCID,Jeffreys Amy S.²,Coffman Cynthia J.²³,Alexopoulos Anastasia-Stefania⁴,Tarkington Phillip E.⁵,Bosworth Hayden¹²⁶,Edelman David¹²,Crowley Matthew J.²⁴

Affiliation:

1. Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

2. Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Transformation, Durham, North Carolina, USA.

3. Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA.

4. Division of Endocrinology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina; USA.

5. Central Virginia VA Health Care System, Department of Veterans Affairs, Richmond, Virginia, USA.

6. Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/tmj.2023.0453

Reference34 articles.

1. Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006–2013

2. Addressing Therapeutic Inertia in 2020 and Beyond: A 3-Year Initiative of the American Diabetes Association

3. Clinical Inertia in People With Type 2 Diabetes

4. Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline